Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients

Yumi Nonomura, Atsushi Otsuka, Chisa Nakashima, Judith A. Seidel, Akihiko Kitoh, Teruki Dainichi, Saeko Nakajima, Yu Sawada, Shigeto Matsushita, Megumi Aoki, Tatsuya Takenouchi, Taku Fujimura, Naohito Hatta, Satoshi Koreeda, Satoshi Fukushima, Tetsuya Honda, Kenji Kabashima

Research output: Contribution to journalArticlepeer-review

60 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Peripheral blood Th9 cells are a possible pharmacodynamic biomarker of nivolumab treatment efficacy in metastatic melanoma patients'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology